277 related articles for article (PubMed ID: 31811345)
1. Brain metabolic signatures across the Alzheimer's disease spectrum.
Sala A; Caprioglio C; Santangelo R; Vanoli EG; Iannaccone S; Magnani G; Perani D
Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):256-269. PubMed ID: 31811345
[TBL] [Abstract][Full Text] [Related]
2. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
[TBL] [Abstract][Full Text] [Related]
4. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
[TBL] [Abstract][Full Text] [Related]
5. Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer's Disease.
Bergeron D; Beauregard JM; Soucy JP; Verret L; Poulin S; Matias-Guiu JA; Cabrera-Martín MN; Bouchard RW; Laforce R
J Alzheimers Dis; 2020; 77(4):1569-1577. PubMed ID: 32925054
[TBL] [Abstract][Full Text] [Related]
6. Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.
Roy K; Pepin LC; Philiossaint M; Lorius N; Becker JA; Locascio JJ; Rentz DM; Sperling RA; Johnson KA; Marshall GA
J Alzheimers Dis; 2014; 42(1):291-300. PubMed ID: 24898635
[TBL] [Abstract][Full Text] [Related]
7. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD.
Kantarci K; Boeve BF; Przybelski SA; Lesnick TG; Chen Q; Fields J; Schwarz CG; Senjem ML; Gunte JL; Jack CR; Min P; Jain M; Miyagawa T; Savica R; Graff-Radford J; Botha H; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Petersen RC; Lowe VJ
Neuroimage Clin; 2021; 31():102754. PubMed ID: 34252877
[TBL] [Abstract][Full Text] [Related]
8. The Behavioral/Dysexecutive Variant of Alzheimer's Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization.
Bergeron D; Sellami L; Poulin S; Verret L; Bouchard RW; Laforce R
Dement Geriatr Cogn Disord; 2020; 49(5):518-525. PubMed ID: 33207355
[TBL] [Abstract][Full Text] [Related]
9. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
Madhavan A; Whitwell JL; Weigand SD; Duffy JR; Strand EA; Machulda MM; Tosakulwong N; Senjem ML; Gunter JL; Lowe VJ; Petersen RC; Jack CR; Josephs KA
PLoS One; 2013; 8(4):e62471. PubMed ID: 23626825
[TBL] [Abstract][Full Text] [Related]
10. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
[TBL] [Abstract][Full Text] [Related]
11. Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration.
Levin F; Ferreira D; Lange C; Dyrba M; Westman E; Buchert R; Teipel SJ; Grothe MJ;
Alzheimers Res Ther; 2021 Feb; 13(1):49. PubMed ID: 33608059
[TBL] [Abstract][Full Text] [Related]
12. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
[TBL] [Abstract][Full Text] [Related]
13. The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease.
Tondo G; Iaccarino L; Caminiti SP; Presotto L; Santangelo R; Iannaccone S; Magnani G; Perani D
Alzheimers Res Ther; 2020 Apr; 12(1):50. PubMed ID: 32354345
[TBL] [Abstract][Full Text] [Related]
14. Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer's Disease Corresponding to Brain Networks: a Prospective Cohort Study.
Wang Y; Shi Z; Zhang N; Cai L; Li Y; Yang H; Yao S; Xing X; Ji Y; Gao S
Mol Imaging Biol; 2019 Feb; 21(1):140-148. PubMed ID: 29869063
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of FDG-PET for the clinical diagnosis in MCI.
Arbizu J; Festari C; Altomare D; Walker Z; Bouwman F; Rivolta J; Orini S; Barthel H; Agosta F; Drzezga A; Nestor P; Boccardi M; Frisoni GB; Nobili F;
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1497-1508. PubMed ID: 29704037
[TBL] [Abstract][Full Text] [Related]
16. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S
Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111
[TBL] [Abstract][Full Text] [Related]
17. Brain Metabolism and Microglia Activation in Mild Cognitive Impairment: A Combined [18F]FDG and [11C]-(R)-PK11195 PET Study.
Tondo G; Boccalini C; Caminiti SP; Presotto L; Filippi M; Magnani G; Frisoni GB; Iannaccone S; Perani D
J Alzheimers Dis; 2021; 80(1):433-445. PubMed ID: 33579848
[TBL] [Abstract][Full Text] [Related]
18. Biomarker-based stability in limbic-predominant amnestic mild cognitive impairment.
Tondo G; Carli G; Santangelo R; Mattoli MV; Presotto L; Filippi M; Magnani G; Iannaccone S; Cerami C; Perani D;
Eur J Neurol; 2021 Apr; 28(4):1123-1133. PubMed ID: 33185922
[TBL] [Abstract][Full Text] [Related]
19. Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
Lee YH; Jeon S; Yoo HS; Chung SJ; Jung JH; Baik K; Sohn YH; Lee PH; Yun M; Evans AC; Ye BS
J Alzheimers Dis; 2021; 79(4):1471-1487. PubMed ID: 33459638
[TBL] [Abstract][Full Text] [Related]
20. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.
Mosconi L; Tsui WH; Herholz K; Pupi A; Drzezga A; Lucignani G; Reiman EM; Holthoff V; Kalbe E; Sorbi S; Diehl-Schmid J; Perneczky R; Clerici F; Caselli R; Beuthien-Baumann B; Kurz A; Minoshima S; de Leon MJ
J Nucl Med; 2008 Mar; 49(3):390-8. PubMed ID: 18287270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
